Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Hereditary Cancer Panel Comprehensive Molecular Genetics Laboratory London Health Sciences Centre Canada | 39 | 30 |
|
Genesys Diagnostics Genesys Diagnostics, Inc. United States | 58 | 43 |
|
Hereditary Cancer Screening - Common Hereditary Cancer Panel (41 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 47 | 41 |
|
Hereditary Cancer Screening - Nervous System & Endocrine Cancer Panel (44 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 52 | 44 |
|
Genesys Diagnostics Genesys Diagnostics, Inc. United States | 40 | 39 |
|
Hereditary Cancer Screening - Breast & Gynecological Cancer Panel (33 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 37 | 33 |
|
Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 109 | 99 |
|
Hereditary Colon and Endometrial Cancer-ColoNGS GeneKor MSA Greece | 10 | 7 |
|
Hereditary Non-Polyposis Colorectal Cancer (HNPCC) or Lynch Syndrome GeneKor MSA Greece | 7 | 5 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 59 | 16 |
|
Common Hereditary Cancer Screening Panel PreventionGenetics, part of Exact Sciences United States | 94 | 55 |
|
Centogene AG - the Rare Disease Company Germany | 58 | 28 |
|
Centogene AG - the Rare Disease Company Germany | 67 | 33 |
|
Centogene AG - the Rare Disease Company Germany | 113 | 68 |
|
Centogene AG - the Rare Disease Company Germany | 155 | 107 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
MLH1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
MSH2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.